The expanding complexity of estrogen receptor signaling in the cardiovascular system

Circulation Research

Volumn 118, Issue 6, 2016, Pages 994-1007

  Menazza, Sara ^a   Murphy, Elizabeth ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

estrogens; MAP kinase signaling pathways; PI3 kinases; receptors, G protein coupled; signal transduction

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR; PROTEIN BINDING;

AGING; CARDIOVASCULAR SYSTEM; CELL MEMBRANE; CELL MIGRATION; ENDOPLASMIC RETICULUM MEMBRANE; ENDOTHELIUM CELL; ESTROGEN ACTIVITY; GENE EXPRESSION; GENOMICS; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALS; CARDIOVASCULAR SYSTEM; ESTROGENS; HUMANS; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 84954342002     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.305376     Document Type: Review

References (167)

1. Mendelsohn ME, Karas RH, Molecular and cellular basis of cardiovascular gender differences. Science 2005 308 1583 1587. doi: 10.1126/science.1112062
2. Barrett-Connor E, Bush TL, Estrogen and coronary heart disease in women. JAMA 1991 265 1861 1867
3. Babiker FA, Joseph S, Juggi J, The protective effects of 17beta-estradiol against ischemia-reperfusion injury and its effect on pacing postconditioning protection to the heart. J Physiol Biochem 2014 70 151 162. doi: 10.1007/s13105-013-0289-9
4. Skavdahl M, Steenbergen C, Clark J, Myers P, Demianenko T, Mao L, Rockman HA, Korach KS, Murphy E, Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy. Am J Physiol Heart Circ Physiol 2005 288 H469 H476. doi: 10.1152/ajpheart.00723.2004
5. Patten RD, Karas RH, Estrogen replacement and cardiomyocyte protection. Trends Cardiovasc Med 2006 16 69 75. doi: 10.1016/j.tcm.2006.01.002
6. Hodis HN, Mack WJ, Azen SP, Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 2003 349 535 545. doi: 10.1056/NEJMoa030830
7. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N, HERS Research Group Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002 288 49 57
8. Manson JE, Chlebowski RT, Stefanick ML, Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013 310 1353 1368. doi: 10.1001/jama.2013.278040
9. Sasaki H, Nagayama T, Blanton RM, PDE5 inhibitor efficacy is estrogen dependent in female heart disease. J Clin Invest 2014 124 2464 2471. doi: 10.1172/JCI70731
10. Murphy E, Steenbergen C, Sex, drugs, and trial design: sex influences the heart and drug responses. J Clin Invest 2014 124 2375 2377. doi: 10.1172/JCI76262
11. Clayton JA, Collins FS, Policy: NIH to balance sex in cell and animal studies. Nature 2014 509 282 283
12. Razandi M, Alton G, Pedram A, Ghonshani S, Webb P, Levin ER, Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol Cell Biol 2003 23 1633 1646
13. Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, Visca P, Marino M, Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol Biol Cell 2005 16 231 237. doi: 10.1091/mbc.E04-07-0547
14. Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER, A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 2007 282 22278 22288. doi: 10.1074/jbc.M611877200
15. Mosselman S, Polman J, Dijkema R, ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996 392 49 53
16. Hall JM, Couse JF, Korach KS, The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001 276 36869 36872. doi: 10.1074/jbc.R100029200
17. Burns KA, Li Y, Arao Y, Petrovich RM, Korach KS, Selective mutations in estrogen receptor alpha D-domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms. J Biol Chem 2011 286 12640 12649. doi: 10.1074/jbc.M110.187773
18. Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, Jameson JL, Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem 2001 276 13615 13621. doi: 10.1074/jbc.M008384200
19. Thomas RS, Sarwar N, Phoenix F, Coombes RC, Ali S, Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity. J Mol Endocrinol 2008 40 173 184. doi: 10.1677/JME-07-0165
20. Curtis SW, Washburn T, Sewall C, DiAugustine R, Lindzey J, Couse JF, Korach KS, Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc Natl Acad Sci USA 1996 93 12626 12630
21. Otsuki M, Gao H, Dahlman-Wright K, Ohlsson C, Eguchi N, Urade Y, Gustafsson JA, Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor beta. Mol Endocrinol 2003 17 1844 1855. doi: 10.1210/me.2003-0016
22. Pedram A, Razandi M, Aitkenhead M, Levin ER, Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1. J Biol Chem 2005 280 26339 26348. doi: 10.1074/jbc.M414409200
23. Strehlow K, Rotter S, Wassmann S, Adam O, Grohé C, Laufs K, Böhm M, Nickenig G, Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 2003 93 170 177. doi: 10.1161/01.RES.0000082334.17947.11
24. Saito T, Ciobotaru A, Bopassa JC, Toro L, Stefani E, Eghbali M, Estrogen contributes to gender differences in mouse ventricular repolarization. Circ Res 2009 105 343 352. doi: 10.1161/CIRCRESAHA.108.190041
25. Caulin-Glaser T, Watson CA, Pardi R, Bender JR, Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 1996 98 36 42. doi: 10.1172/JCI118774
26. Johnson BD, Zheng W, Korach KS, Scheuer T, Catterall WA, Rubanyi GM, Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. J Gen Physiol 1997 110 135 140
27. Voss MR, Stallone JN, Li M, Cornelussen RN, Knuefermann P, Knowlton AA, Gender differences in the expression of heat shock proteins: the effect of estrogen. Am J Physiol Heart Circ Physiol 2003 285 H687 H692. doi: 10.1152/ajpheart.01000.2002
28. Pechenino AS, Lin L, Mbai FN, Lee AR, He XM, Stallone JN, Knowlton AA, Impact of aging vs. estrogen loss on cardiac gene expression: estrogen replacement and inflammation. Physiol Genomics 2011 43 1065 1073. doi: 10.1152/physiolgenomics.00228.2010
29. Hamilton KL, Lin L, Wang Y, Knowlton AA, Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression. Physiol Genomics 2008 32 254 263. doi: 10.1152/physiolgenomics.00039.2007
30. Chambliss KL, Shaul PW, Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 2002 23 665 686. doi: 10.1210/er.2001-0045
31. Jun SS, Chen Z, Pace MC, Shaul PW, Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. J Clin Invest 1998 102 176 183. doi: 10.1172/JCI2034
32. Wingrove CS, Garr E, Godsland IF, Stevenson JC, 17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1998 1406 169 174
33. Akishita M, Kozaki K, Eto M, Yoshizumi M, Ishikawa M, Toba K, Orimo H, Ouchi Y, Estrogen attenuates endothelin-1 production by bovine endothelial cells via estrogen receptor. Biochem Biophys Res Commun 1998 251 17 21. doi: 10.1006/bbrc.1998.9409
34. Nickenig G, Strehlow K, Wassmann S, Bäumer AT, Albory K, Sauer H, Böhm M, Differential effects of estrogen and progesterone on AT(1) receptor gene expression in vascular smooth muscle cells. Circulation 2000 102 1828 1833
35. Devanathan S, Whitehead T, Schweitzer GG, Fettig N, Kovacs A, Korach KS, Finck BN, Shoghi KI, An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: functional, metabolic, and differential network analysis. PLoS One 2014 9 e101900. doi: 10.1371/journal.pone.0101900
36. Kararigas G, Bito V, Tinel H, Becher E, Baczko I, Knosalla C, Albrecht-Küpper B, Sipido KR, Regitz-Zagrosek V, Transcriptome characterization of estrogen-treated human myocardium identifies myosin regulatory light chain interacting protein as a sex-specific element influencing contractile function. J Am Coll Cardiol 2012 59 410 417. doi: 10.1016/j.jacc.2011.09.054
37. Lindberg MK, Movérare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, Ohlsson C, Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a ying yang relationship between ERalpha and ERbeta in mice. Mol Endocrinol 2003 17 203 208. doi: 10.1210/me.2002-0206
38. Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS, Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 1997 138 4613 4621. doi: 10.1210/endo.138.11.5496
39. Nuedling S, Kahlert S, Loebbert K, Doevendans PA, Meyer R, Vetter H, Grohé C, 17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. Cardiovasc Res 1999 43 666 674
40. O'Lone R, Knorr K, Jaffe IZ, Schaffer ME, Martini PG, Karas RH, Bienkowska J, Mendelsohn ME, Hansen U, Estrogen receptors alpha and beta mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species. Mol Endocrinol 2007 21 1281 1296. doi: 10.1210/me.2006-0497
41. Nikolic I, Liu D, Bell JA, Collins J, Steenbergen C, Murphy E, Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J Mol Cell Cardiol 2007 42 769 780. doi: 10.1016/j.yjmcc.2007.01.014
42. Shang Y, Brown M, Molecular determinants for the tissue specificity of SERMs. Science 2002 295 2465 2468. doi: 10.1126/science.1068537
43. Rosenfeld MG, Glass CK, Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 2001 276 36865 36868. doi: 10.1074/jbc.R100041200
44. Hewitt SC, Deroo BJ, Hansen K, Collins J, Grissom S, Afshari CA, Korach KS, Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. Mol Endocrinol 2003 17 2070 2083. doi: 10.1210/me.2003-0146
45. Tan E, Gurjar MV, Sharma RV, Bhalla RC, Estrogen receptor-alpha gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration. Cardiovasc Res 1999 43 788 797
46. Nuedling S, Karas RH, Mendelsohn ME, Katzenellenbogen JA, Katzenellenbogen BS, Meyer R, Vetter H, Grohé C, Activation of estrogen receptor beta is a prerequisite for estrogen-dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes. FEBS Lett 2001 502 103 108
47. Tsutsumi S, Zhang X, Takata K, Takahashi K, Karas RH, Kurachi H, Mendelsohn ME, Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2. J Endocrinol 2008 199 267 273. doi: 10.1677/JOE-07-0292
48. Chen LC, Lee WS, Estradiol reduces ferrous citrate complex-induced NOS2 up-regulation in cerebral endothelial cells by interfering the nuclear factor kappa B transactivation through an estrogen receptor β-mediated pathway. PLoS One 2013 8 e84320. doi: 10.1371/journal.pone.0084320
49. Liu Z, Gou Y, Zhang H, Zuo H, Zhang H, Liu Z, Yao D, Estradiol improves cardiovascular function through up-regulation of SOD2 on vascular wall. Redox Biol 2014 3 88 99. doi: 10.1016/j.redox.2014.11.001
50. Mahmoodzadeh S, Leber J, Zhang X, Jaisser F, Messaoudi S, Morano I, Furth PA, Dworatzek E, Regitz-Zagrosek V, Cardiomyocyte-specific estrogen receptor alpha increases angiogenesis, lymphangiogenesis and reduces fibrosis in the female mouse heart post-myocardial infarction. J Cell Sci Ther 2014 5 153. doi: 10.4172/2157-7013.1000153
51. Pelzer T, Jazbutyte V, Hu K, Segerer S, Nahrendorf M, Nordbeck P, Bonz AW, Muck J, Fritzemeier KH, Hegele-Hartung C, Ertl G, Neyses L, The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovasc Res 2005 67 604 612. doi: 10.1016/j.cardiores.2005.04.035
52. Korte T, Fuchs M, Arkudas A, Geertz S, Meyer R, Gardiwal A, Klein G, Niehaus M, Krust A, Chambon P, Drexler H, Fink K, Grohé C, Female mice lacking estrogen receptor beta display prolonged ventricular repolarization and reduced ventricular automaticity after myocardial infarction. Circulation 2005 111 2282 2290. doi: 10.1161/01.CIR.0000164262.08004.BB
53. Jeanes HL, Tabor C, Black D, Ederveen A, Gray GA, Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)alpha agonist and unaffected by an ER beta antagonist. J Endocrinol 2008 197 493 501. doi: 10.1677/JOE-08-0071
54. Booth EA, Obeid NR, Lucchesi BR, Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2005 289 H2039 H2047. doi: 10.1152/ajpheart.00479.2005
55. Favre J, Gao J, Henry JP, Remy-Jouet I, Fourquaux I, Billon-Gales A, Thuillez C, Arnal JF, Lenfant F, Richard V, Endothelial estrogen receptor {alpha} plays an essential role in the coronary and myocardial protective effects of estradiol in ischemia/reperfusion. Arterioscler Thromb Vasc Biol 2010 30 2562 2567. doi: 10.1161/ATVBAHA.110.213637
56. Barros RP, Machado UF, Warner M, Gustafsson JA, Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc Natl Acad Sci USA 2006 103 1605 1608. doi: 10.1073/pnas.0510391103
57. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson JA, Mendelsohn ME, Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002 295 505 508. doi: 10.1126/science.1065250
58. Kararigas G, Nguyen BT, Jarry H, Estrogen modulates cardiac growth through an estrogen receptor α-dependent mechanism in healthy ovariectomized mice. Mol Cell Endocrinol 2014 382 909 914. doi: 10.1016/j.mce.2013.11.011
59. Dworatzek E, Mahmoodzadeh S, Schubert C, Westphal C, Leber J, Kusch A, Kararigas G, Fliegner D, Moulin M, Ventura-Clapier R, Gustafsson JA, Davidson MM, Dragun D, Regitz-Zagrosek V, Sex differences in exercise-induced physiological myocardial hypertrophy are modulated by oestrogen receptor beta. Cardiovasc Res 2014 102 418 428. doi: 10.1093/cvr/cvu065
60. Lagranha CJ, Deschamps A, Aponte A, Steenbergen C, Murphy E, Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ Res 2010 106 1681 1691. doi: 10.1161/CIRCRESAHA.109.213645
61. Yan L, Ge H, Li H, Gender-specific proteomic alterations in glycolytic and mitochondrial pathways in aging monkey hearts. J Mol Cell Cardiol 2004 37 921 929. doi: 10.1016/j.yjmcc.2004.06.012
62. Salgado RM, Covarrubias AC, Favaro RR, Serrano-Nascimento C, Nunes MT, Zorn TM, Estradiol induces transcriptional and posttranscriptional modifications in versican expression in the mouse uterus. J Mol Histol 2013 44 221 229. doi: 10.1007/s10735-012-9476-1
63. Zhang X, Moor AN, Merkler KA, Liu Q, McLean MP, Regulation of alternative splicing of liver scavenger receptor class B gene by estrogen and the involved regulatory splicing factors. Endocrinology 2007 148 5295 5304. doi: 10.1210/en.2007-0376
64. Dago DN, Scafoglio C, Rinaldi A, Memoli D, Giurato G, Nassa G, Ravo M, Rizzo F, Tarallo R, Weisz A, Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells. BMC Genomics 2015 16 367. doi: 10.1186/s12864-015-1541-1
65. Bhat-Nakshatri P, Song EK, Collins NR, Uversky VN, Dunker AK, O'Malley BW, Geistlinger TR, Carroll JS, Brown M, Nakshatri H, Interplay between estrogen receptor and AKT in estradiol-induced alternative splicing. BMC Med Genomics 2013 6 21. doi: 10.1186/1755-8794-6-21
66. Klinge CM, miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Mol Cellular Endocrinol 2015. doi: 10.1016/j.mce.2015.01.035
67. Pietras RJ, Szego CM, Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 1977 265 69 72
68. Simoncini T, Mannella P, Fornari L, Caruso A, Varone G, Genazzani AR, Genomic and non-genomic effects of estrogens on endothelial cells. Steroids 2004 69 537 542. doi: 10.1016/j.steroids.2004.05.009
69. Meyer MR, Haas E, Barton M, Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension 2006 47 1019 1026. doi: 10.1161/01.HYP.0000223064.62762.0b
70. Chen JQ, Delannoy M, Cooke C, Yager JD, Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells. Am J Physiol Endocrinol Metab 2004 286 E1011 E1022. doi: 10.1152/ajpendo.00508.2003
71. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, Shaul PW, Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 2000 87 E44 E52
72. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER, A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005 307 1625 1630. doi: 10.1126/science.1106943
73. Figtree GA, McDonald D, Watkins H, Channon KM, Truncated estrogen receptor alpha 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation 2003 107 120 126
74. Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK, Jo I, Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae. Biochem Biophys Res Commun 1999 263 257 262. doi: 10.1006/bbrc.1999.1348
75. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR, Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 2000 87 677 682
76. Harrington WR, Kim SH, Funk CC, Madak-Erdogan Z, Schiff R, Katzenellenbogen JA, Katzenellenbogen BS, Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol Endocrinol 2006 20 491 502. doi: 10.1210/me.2005-0186
77. Pedram A, Razandi M, Levin ER, Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 2006 20 1996 2009. doi: 10.1210/me.2005-0525
78. Huang B, Omoto Y, Iwase H, Yamashita H, Toyama T, Coombes RC, Filipovic A, Warner M, Gustafsson JÅ Differential expression of estrogen receptor α β1, and β2 in lobular and ductal breast cancer. Proc Natl Acad Sci USA 2014 111 1933 1938. doi: 10.1073/pnas.1323719111
79. Irsik DL, Carmines PK, Lane PH, Classical estrogen receptors and ERα splice variants in the mouse. PLoS One 2013 8 e70926. doi: 10.1371/journal.pone.0070926
80. Guo X, Razandi M, Pedram A, Kassab G, Levin ER, Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J Biol Chem 2005 280 19704 19710. doi: 10.1074/jbc.M501244200
81. Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW, ERbeta has nongenomic action in caveolae. Mol Endocrinol 2002 16 938 946. doi: 10.1210/mend.16.5.0827
82. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER, Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol 2004 18 2854 2865. doi: 10.1210/me.2004-0115
83. Acconcia F, Ascenzi P, Fabozzi G, Visca P, Marino M, S-palmitoylation modulates human estrogen receptor-alpha functions. Biochem Biophys Res Commun 2004 316 878 883. doi: 10.1016/j.bbrc.2004.02.129
84. Kumar P, Wu Q, Chambliss KL, Yuhanna IS, Mumby SM, Mineo C, Tall GG, Shaul PW, Direct interactions with G α i and G βγ mediate nongenomic signaling by estrogen receptor α. Mol Endocrinol 2007 21 1370 1380. doi: 10.1210/me.2006-0360
85. Li L, Haynes MP, Bender JR, Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 2003 100 4807 4812. doi: 10.1073/pnas.0831079100
86. Stirone C, Boroujerdi A, Duckles SP, Krause DN, Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol Pharmacol 2005 67 105 113. doi: 10.1124/mol.104.004465
87. Li L, Hisamoto K, Kim KH, Haynes MP, Bauer PM, Sanjay A, Collinge M, Baron R, Sessa WC, Bender JR, Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation. Proc Natl Acad Sci USA 2007 104 16468 16473. doi: 10.1073/pnas.0704315104
88. Razandi M, Pedram A, Levin ER, Heat shock protein 27 is required for sex steroid receptor trafficking to and functioning at the plasma membrane. Mol Cell Biol 2010 30 3249 3261. doi: 10.1128/MCB.01354-09
89. Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME, Karas RH, Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci USA 2004 101 17126 17131. doi: 10.1073/pnas.0407492101
90. Simoncini T, Rabkin E, Liao JK, Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells. Arterioscler Thromb Vasc Biol 2003 23 198 203
91. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV, Auricchio F, PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 2001 20 6050 6059. doi: 10.1093/emboj/20.21.6050
92. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK, Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000 407 538 541. doi: 10.1038/35035131
93. Klinge CM, Blankenship KA, Risinger KE, Bhatnagar S, Noisin EL, Sumanasekera WK, Zhao L, Brey DM, Keynton RS, Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem 2005 280 7460 7468. doi: 10.1074/jbc.M411565200
94. Zhang Z, Maier B, Santen RJ, Song RX, Membrane association of estrogen receptor alpha mediates estrogen effect on MAPK activation. Biochem Biophys Res Commun 2002 294 926 933. doi: 10.1016/S0006-291X(02)00348-0
95. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW, Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol 1997 273 L119 L126
96. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW, Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999 103 401 406. doi: 10.1172/JCI5347
97. Walker HA, Dean TS, Sanders TA, Jackson G, Ritter JM, Chowienczyk PJ, The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17beta-estradiol. Circulation 2001 103 258 262
98. Mendelsohn ME, Nongenomic, ER-mediated activation of endothelial nitric oxide synthase: how does it work? What does it mean? Circ Res 2000 87 956 960
99. Khazaei M, Moien-Afshari F, Laher I, Vascular endothelial function in health and diseases. Pathophysiology 2008 15 49 67. doi: 10.1016/j.pathophys.2008.02.002
100. Haynes MP, Li L, Sinha D, Russell KS, Hisamoto K, Baron R, Collinge M, Sessa WC, Bender JR, Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem 2003 278 2118 2123. doi: 10.1074/jbc.M210828200
101. Le Romancer M, Treilleux I, Leconte N, Robin-Lespinasse Y, Sentis S, Bouchekioua-Bouzaghou K, Goddard S, Gobert-Gosse S, Corbo L, Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol Cell 2008 31 212 221. doi: 10.1016/j.molcel.2008.05.025
102. Wu Q, Chambliss K, Lee WR, Yuhanna IS, Mineo C, Shaul PW, Point mutations in the ERα Gαi binding domain segregate nonnuclear from nuclear receptor function. Mol Endocrinol 2013 27 2 11. doi: 10.1210/me.2011-1378
103. Chambliss KL, Wu Q, Oltmann S, Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest 2010 120 2319 2330. doi: 10.1172/JCI38291
104. Bernelot Moens SJ, Schnitzler GR, Nickerson M, Guo H, Ueda K, Lu Q, Aronovitz MJ, Nickerson H, Baur WE, Hansen U, Iyer LK, Karas RH, Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury. Circulation 2012 126 1993 2004. doi: 10.1161/CIRCULATIONAHA.112.124529
105. Stefano GB, Prevot V, Beauvillain JC, Cadet P, Fimiani C, Welters I, Fricchione GL, Breton C, Lassalle P, Salzet M, Bilfinger TV, Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation 2000 101 1594 1597
106. Rubio-Gayosso I, Sierra-Ramirez A, García-Vazquez A, Martinez-Martinez A, Muñoz-García O, Morato T, Ceballos-Reyes G, 17Beta-estradiol increases intracellular calcium concentration through a short-term and nongenomic mechanism in rat vascular endothelium in culture. J Cardiovasc Pharmacol 2000 36 196 202
107. Ortmann J, Veit M, Zingg S, Di Santo S, Traupe T, Yang Z, Völzmann J, Dubey RK, Christen S, Baumgartner I, Estrogen receptor-α but not -β or GPER inhibits high glucose-induced human VSMC proliferation: potential role of ROS and ERK. J Clin Endocrinol Metab 2011 96 220 228. doi: 10.1210/jc.2010-0943
108. Li QY, Chen L, Zhu YH, Zhang M, Wang YP, Wang MW, Involvement of estrogen receptor-β in farrerol inhibition of rat thoracic aorta vascular smooth muscle cell proliferation. Acta Pharmacol Sin 2011 32 433 440. doi: 10.1038/aps.2011.1
109. Lu Q, Surks HK, Ebling H, Baur WE, Brown D, Pallas DC, Karas RH, Regulation of estrogen receptor alpha-mediated transcription by a direct interaction with protein phosphatase 2A. J Biol Chem 2003 278 4639 4645. doi: 10.1074/jbc.M210949200
110. Yang L, Wang Y, Chen P, Hu J, Xiong Y, Feng D, Liu H, Zhang H, Yang H, He J, Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression. Endocrinology 2011 152 4537 4549. doi: 10.1210/en.2011-1207
111. Ueda K, Lu Q, Baur W, Aronovitz MJ, Karas RH, Rapid estrogen receptor signaling mediates estrogen-induced inhibition of vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol 2013 33 1837 1843. doi: 10.1161/ATVBAHA.112.300752
112. Fukumoto T, Tawa M, Yamashita N, Ohkita M, Matsumura Y, Protective effects of 17beta-estradiol on post-ischemic cardiac dysfunction and norepinephrine overflow through the non-genomic estrogen receptor/nitric oxide-mediated pathway in the rat heart. Eur J Pharmacol 2013 699 74 80. doi: 10.1016/j.ejphar.2012.11.042
113. Babiker FA, Lips D, Meyer R, Delvaux E, Zandberg P, Janssen B, van Eys G, Grohé C, Doevendans PA, Estrogen receptor beta protects the murine heart against left ventricular hypertrophy. Arterioscler Thromb Vasc Biol 2006 26 1524 1530. doi: 10.1161/01.ATV.0000223344.11128.23
114. Pedram A, Razandi M, Lubahn D, Liu J, Vannan M, Levin ER, Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin. Endocrinology 2008 149 3361 3369. doi: 10.1210/en.2008-0133
115. Cavasin MA, Stenmark KR, McKinsey TA, Emerging roles for histone deacetylases in pulmonary hypertension and right ventricular remodeling (2013 Grover Conference series). Pulm Circ 2015 5 63 72. doi: 10.1086/679700
116. Pedram A, Razandi M, Narayanan R, Dalton JT, McKinsey TA, Levin ER, Estrogen regulates histone deacetylases to prevent cardiac hypertrophy. Mol Biol Cell 2013 24 3805 3818. doi: 10.1091/mbc.E13-08-0444
117. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr., Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000 14 1649 1660. doi: 10.1210/mend.14.10.0532
118. Thomas P, Pang Y, Filardo EJ, Dong J, Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005 146 624 632. doi: 10.1210/en.2004-1064
119. O'Dowd BF, Nguyen T, Marchese A, Cheng R, Lynch KR, Heng HH, Kolakowski LF Jr, George SR, Discovery of three novel G-protein-coupled receptor genes. Genomics 1998 47 310 313. doi: 10.1006/geno.1998.5095
120. Haas E, Meyer MR, Schurr U, Bhattacharya I, Minotti R, Nguyen HH, Heigl A, Lachat M, Genoni M, Barton M, Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension 2007 49 1358 1363. doi: 10.1161/HYPERTENSIONAHA.107.089995
121. Funakoshi T, Yanai A, Shinoda K, Kawano MM, Mizukami Y, G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem Biophys Res Commun 2006 346 904 910. doi: 10.1016/j.bbrc.2006.05.191
122. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, Thomas P, Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 2007 148 3236 3245. doi: 10.1210/en.2006-1605
123. Sandén C, Broselid S, Cornmark L, Andersson K, Daszkiewicz-Nilsson J, Mårtensson UE, Olde B, Leeb-Lundberg LM, G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments. Mol Pharmacol 2011 79 400 410. doi: 10.1124/mol.110.069500
124. Cheng SB, Quinn JA, Graeber CT, Filardo EJ, Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway. J Biol Chem 2011 286 22441 22455. doi: 10.1074/jbc.M111.224071
125. Meyer MR, Baretella O, Prossnitz ER, Barton M, Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780. Pharmacology 2010 86 58 64. doi: 10.1159/000315497
126. Sudhir K, Chou TM, Mullen WL, Hausmann D, Collins P, Yock PG, Chatterjee K, Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J Am Coll Cardiol 1995 26 807 814. doi: 10.1016/0735-1097(95)00248-3
127. Shaw L, Taggart MJ, Austin C, Mechanisms of 17 beta-oestradiol induced vasodilatation in isolated pressurized rat small arteries. Br J Pharmacol 2000 129 555 565. doi: 10.1038/sj.bjp.0703084
128. Ullrich ND, Krust A, Collins P, MacLeod KT, Genomic deletion of estrogen receptors ERalpha and ERbeta does not alter estrogen-mediated inhibition of Ca2+ influx and contraction in murine cardiomyocytes. Am J Physiol Heart Circ Physiol 2008 294 H2421 H2427. doi: 10.1152/ajpheart.01225.2007
129. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA, Oprea TI, Prossnitz ER, Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2006 2 207 212. doi: 10.1038/nchembio775
130. Han G, Ma H, Chintala R, Fulton DJ, Barman SA, White RE, Essential role of the 90-kilodalton heat shock protein in mediating nongenomic estrogen signaling in coronary artery smooth muscle. J Pharmacol Exp Ther 2009 329 850 855. doi: 10.1124/jpet.108.149112
131. Lindsey SH, Cohen JA, Brosnihan KB, Gallagher PE, Chappell MC, Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology 2009 150 3753 3758. doi: 10.1210/en.2008-1664
132. Haas E, Bhattacharya I, Brailoiu E, Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 2009 104 288 291. doi: 10.1161/CIRCRESAHA.108.190892
133. Jessup JA, Lindsey SH, Wang H, Chappell MC, Groban L, Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis rats. PLoS One 2010 5 e15433. doi: 10.1371/journal.pone.0015433
134. Lindsey SH, Carver KA, Prossnitz ER, Chappell MC, Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat. J Cardiovasc Pharmacol 2011 57 598 603. doi: 10.1097/FJC.0b013e3182135f1c
135. Broughton BR, Miller AA, Sobey CG, Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries. Am J Physiol Heart Circ Physiol 2010 298 H1055 H1061. doi: 10.1152/ajpheart.00878.2009
136. Yu X, Ma H, Barman SA, Liu AT, Sellers M, Stallone JN, Prossnitz ER, White RE, Han G, Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle. Am J Physiol Endocrinol Metab 2011 301 E882 E888. doi: 10.1152/ajpendo.00037.2011
137. Prossnitz ER, Barton M, Estrogen biology: new insights into GPER function and clinical opportunities. Mol Cell Endocrinol 2014 389 71 83. doi: 10.1016/j.mce.2014.02.002
138. Owens GK, Kumar MS, Wamhoff BR, Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004 84 767 801. doi: 10.1152/physrev.00041.2003
139. Pendaries C, Darblade B, Rochaix P, Krust A, Chambon P, Korach KS, Bayard F, Arnal JF, The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci USA 2002 99 2205 2210. doi: 10.1073/pnas.042688499
140. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P, Mendelsohn ME, Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res 2002 90 1087 1092
141. Smirnova NF, Fontaine C, Buscato M, The activation function-1 of estrogen receptor alpha prevents arterial neointima development through a direct effect on smooth muscle cells. Circ Res 2015 117 770 778. doi: 10.1161/CIRCRESAHA.115.306416
142. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB, O'Donnell TF Jr, Korach KS, Mendelsohn ME, Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med 1997 3 545 548
143. Li F, Yu X, Szynkarski CK, Meng C, Zhou B, Barhoumi R, White RE, Heaps CL, Stallone JN, Han G, Activation of GPER induces differentiation and inhibition of coronary artery smooth muscle cell proliferation. PLoS One 2013 8 e64771. doi: 10.1371/journal.pone.0064771
144. Holm A, Baldetorp B, Olde B, Leeb-Lundberg LM, Nilsson BO, The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle. J Vasc Res 2011 48 327 335. doi: 10.1159/000322578
145. Meyer MR, Prossnitz ER, Barton M, The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascul Pharmacol 2011 55 17 25. doi: 10.1016/j.vph.2011.06.003
146. Deschamps AM, Murphy E, Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol 2009 297 H1806 H1813. doi: 10.1152/ajpheart.00283.2009
147. Bopassa JC, Eghbali M, Toro L, Stefani E, A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2010 298 H16 H23. doi: 10.1152/ajpheart.00588.2009
148. Weil BR, Manukyan MC, Herrmann JL, Wang Y, Abarbanell AM, Poynter JA, Meldrum DR, Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury. Surgery 2010 148 436 443. doi: 10.1016/j.surg.2010.03.011
149. Pedram A, Razandi M, Lewis M, Hammes S, Levin ER, Membrane-localized estrogen receptor α is required for normal organ development and function. Dev Cell 2014 29 482 490. doi: 10.1016/j.devcel.2014.04.016
150. Adlanmerini M, Solinhac R, Abot A, Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc Natl Acad Sci USA 2014 111 E283 E290. doi: 10.1073/pnas.1322057111
151. Pedram A, Razandi M, O'Mahony F, Harvey H, Harvey BJ, Levin ER, Estrogen reduces lipid content in the liver exclusively from membrane receptor signaling. Sci Signal 2013 6 (276) ra36. doi: 10.1126/scisignal.2004013
152. Karin M, The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995 270 16483 16486
153. Marino M, Acconcia F, Bresciani F, Weisz A, Trentalance A, Distinct nongenomic signal transduction pathways controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells. Mol Biol Cell 2002 13 3720 3729. doi: 10.1091/mbc.E02-03-0153
154. Dos Santos EG, Dieudonne MN, Pecquery R, Le Moal V, Giudicelli Y, Lacasa D, Rapid nongenomic E2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes. Endocrinology 2002 143 930 940. doi: 10.1210/endo.143.3.8678
155. Kawagoe J, Ohmichi M, Takahashi T, Ohshima C, Mabuchi S, Takahashi K, Igarashi H, Mori-Abe A, Saitoh M, Du B, Ohta T, Kimura A, Kyo S, Inoue M, Kurachi H, Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line. J Biol Chem 2003 278 43363 43372. doi: 10.1074/jbc.M304363200
156. Madak-Erdogan Z, Kieser KJ, Kim SH, Komm B, Katzenellenbogen JA, Katzenellenbogen BS, Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol Endocrinol 2008 22 2116 2127. doi: 10.1210/me.2008-0059
157. Mendelsohn ME, Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 2002 90 3F 6F
158. Hodges YK, Tung L, Yan XD, Graham JD, Horwitz KB, Horwitz LD, Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation 2000 101 1792 1798
159. Andersson C, Lydrup ML, Fernö M, Idvall I, Gustafsson J, Nilsson BO, Immunocytochemical demonstration of oestrogen receptor beta in blood vessels of the female rat. J Endocrinol 2001 169 241 247
160. Ihionkhan CE, Chambliss KL, Gibson LL, Hahner LD, Mendelsohn ME, Shaul PW, Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ Res 2002 91 814 820
161. Pinzone JJ, Stevenson H, Strobl JS, Berg PE, Molecular and cellular determinants of estrogen receptor alpha expression. Mol Cell Biol 2004 24 4605 4612. doi: 10.1128/MCB.24.11.4605-4612.2004
162. Wynne FL, Payne JA, Cain AE, Reckelhoff JF, Khalil RA, Age-related reduction in estrogen receptor-mediated mechanisms of vascular relaxation in female spontaneously hypertensive rats. Hypertension 2004 43 405 412. doi: 10.1161/01.HYP.0000111833.82664.0c
163. Gavin KM, Seals DR, Silver AE, Moreau KL, Vascular endothelial estrogen receptor alpha is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women. J Clin Endocrinol Metab 2009 94 3513 3520. doi: 10.1210/jc.2009-0278
164. Arimoto JM, Wong A, Rozovsky I, Lin SW, Morgan TE, Finch CE, Age increase of estrogen receptor-α (ERα) in cortical astrocytes impairs neurotrophic support in male and female rats. Endocrinology 2013 154 2101 2113. doi: 10.1210/en.2012-2046
165. Wu D, Lin G, Gore AC, Age-related changes in hypothalamic androgen receptor and estrogen receptor alpha in male rats. J Comp Neurol 2009 512 688 701. doi: 10.1002/cne.21925
166. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, Ouyang P, Milliken EE, Issa JP, Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999 43 985 991
167. Lin HF, Hsi E, Liao YC, Chhor B, Hung J, Juo SH, Lin RT, Demethylation of circulating estrogen receptor alpha gene in cerebral ischemic stroke. PLoS One 2015 10 e0139608. doi: 10.1371/journal.pone.0139608